Combating Cadmium-Induced Neurotoxicity, Oxidative Stress, and Inflammatory Pathways Using DOPA-31, a

Santhanam Sanjai Dharshan1, S Madesh1, Karthikeyan Ramamurthy1

  • 1Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulatur, Chengalpattu District, Tamil Nadu, India.

Summary

Cadmium exposure causes neurodegeneration and behavioral deficits. The novel drug DOPA-31 effectively reversed these effects by reducing oxidative stress and inflammation, showing potential for treating neurodegenerative disorders.

Related Concept Videos